Cirius withdraws $86M IPO as vaunted 'Year of NASH' draws to brutal close
Cirius Therapeutics didn’t wait for the government shutdown to end before it filed its IPO in January. It was, as JP Morgan analysts had predicted the month prior, “The Year of NASH” and Cirius believed their Phase II program could raise $86 million.
Today, eleven months and a slew of industry-wide NASH failures later, Cirius is withdrawing their IPO. The news adds perhaps 2019’s final nail in expectations that were first buried months ago.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.